March 7, 2019
FDA fast-tracks cancer AI. This morning Paige.AI, a pathology company that uses artificial intelligence for diagnosis and development, was granted a Breakthrough Device designation by the FDA. Page.AI has been working with Memorial Sloan Kettering Cancer Center to digitize pathology slide and create a pathology dataset.
“Paige.AI is focused on providing artificial intelligence tools to...